CN101029336A - 预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 - Google Patents
预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 Download PDFInfo
- Publication number
- CN101029336A CN101029336A CNA2006100579541A CN200610057954A CN101029336A CN 101029336 A CN101029336 A CN 101029336A CN A2006100579541 A CNA2006100579541 A CN A2006100579541A CN 200610057954 A CN200610057954 A CN 200610057954A CN 101029336 A CN101029336 A CN 101029336A
- Authority
- CN
- China
- Prior art keywords
- reuptake inhibitor
- serotonin reuptake
- pleomorphism site
- inhibitor class
- class medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
实际临床缓解人数 | 实际无临床缓解人数 | 合计(人数) | |
预测临床缓解(阳性人数)预测无临床缓解(阴性人数)合计(人数) | 17226198 | 235174 | 19577272 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100579541A CN101029336B (zh) | 2006-03-01 | 2006-03-01 | 预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100579541A CN101029336B (zh) | 2006-03-01 | 2006-03-01 | 预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101029336A true CN101029336A (zh) | 2007-09-05 |
CN101029336B CN101029336B (zh) | 2010-11-03 |
Family
ID=38714887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100579541A Active CN101029336B (zh) | 2006-03-01 | 2006-03-01 | 预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101029336B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
WO2012135975A1 (zh) * | 2011-04-06 | 2012-10-11 | 瑞基海洋生物科技股份有限公司 | 聚合酶链式反应用的混合液 |
CN103898096A (zh) * | 2014-03-27 | 2014-07-02 | 江苏佰龄全基因生物医学技术有限公司 | 一种哺乳动物血液基因组dna提取试剂盒及提取哺乳动物血液基因组dna的方法 |
EP2855706A4 (en) * | 2012-06-01 | 2016-06-08 | Brc Operations Pty Ltd | BIOMARKER FOR TREATMENT RESULTS |
CN106011240A (zh) * | 2016-05-19 | 2016-10-12 | 合肥艾迪康临床检验所有限公司 | 一种融合基因室内质控品、制作方法及其固定液的配方 |
CN111455038A (zh) * | 2020-04-07 | 2020-07-28 | 上海康黎医学检验所有限公司 | 一种用于指导人焦虑症用药的试剂盒及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1465712A (zh) * | 2002-07-05 | 2004-01-07 | 安徽省生物医学研究所 | 一种预测acei类降压药药效的试剂盒、方法、软件和复方药 |
-
2006
- 2006-03-01 CN CN2006100579541A patent/CN101029336B/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
WO2012135975A1 (zh) * | 2011-04-06 | 2012-10-11 | 瑞基海洋生物科技股份有限公司 | 聚合酶链式反应用的混合液 |
CN103443293A (zh) * | 2011-04-06 | 2013-12-11 | 瑞基海洋生物科技股份有限公司 | 聚合酶链式反应用的混合液 |
CN103443293B (zh) * | 2011-04-06 | 2015-04-08 | 瑞基海洋生物科技股份有限公司 | 聚合酶链式反应用的混合液 |
EP2855706A4 (en) * | 2012-06-01 | 2016-06-08 | Brc Operations Pty Ltd | BIOMARKER FOR TREATMENT RESULTS |
CN103898096A (zh) * | 2014-03-27 | 2014-07-02 | 江苏佰龄全基因生物医学技术有限公司 | 一种哺乳动物血液基因组dna提取试剂盒及提取哺乳动物血液基因组dna的方法 |
CN106011240A (zh) * | 2016-05-19 | 2016-10-12 | 合肥艾迪康临床检验所有限公司 | 一种融合基因室内质控品、制作方法及其固定液的配方 |
CN111455038A (zh) * | 2020-04-07 | 2020-07-28 | 上海康黎医学检验所有限公司 | 一种用于指导人焦虑症用药的试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101029336B (zh) | 2010-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arango et al. | Genetics of the serotonergic system in suicidal behavior | |
CN100340674C (zh) | 耳聋相关基因突变及其检测方法 | |
CN1604968A (zh) | 基于tcf1基因多态性治疗糖尿病和相关病症的方法 | |
CN101029336A (zh) | 预测5-羟色胺再摄取抑制剂类药物作用效果的试剂盒 | |
CN1890384A (zh) | 与炎性疾病的治疗功效相关的遗传多态性的用途 | |
CN1612941A (zh) | 基于cntf基因的多态性治疗精神病和精神分裂症的方法 | |
CN101063677A (zh) | 一种预测妊娠不良结局发生风险的试剂盒 | |
CN1754000A (zh) | 预测治疗中自杀行为的方法 | |
WO2010066118A1 (zh) | 抗F4ac仔猪腹泻病的MUC13分子标记及其应用 | |
CN1898394A (zh) | 检测高原肺水肿易感性的方法 | |
CN101029337A (zh) | 多态性位点基因型预测5-羟色胺再摄取抑制剂类药物作用效果的用途和方法 | |
CN105018602B (zh) | 抗精神病药物相关代谢综合征的易感基因及其应用 | |
CN101041854A (zh) | 一种原发性肝癌相关非编码小分子rna的多态性位点及其应用 | |
JP7101961B2 (ja) | ブリ類の性識別方法 | |
CN1357636A (zh) | CpG岛甲基化检测试剂盒及其应用 | |
CN1891822A (zh) | 具有特定单核苷酸多态性的th基因及其检测方法和用途 | |
CN101078027A (zh) | 与肝癌相关的esr1基因多态性及其检测方法 | |
CN101063166A (zh) | 预测血管紧张素转换酶抑制剂类药物作用效果的试剂盒 | |
CN101063678A (zh) | 一种预测妊娠不良结局发生风险的方法 | |
CN1730655A (zh) | 与人类遗传性耳聋相关的gjb6突变基因及其在诊断遗传性耳聋中的应用 | |
CN101008631B (zh) | 预测磺脲类药物疗效的试剂盒 | |
CN1699595A (zh) | 检测与人类遗传性耳聋相关的wfs1基因突变的方法 | |
CN100342032C (zh) | 精神分裂症易感基因检测方法及易感基因和用途 | |
CN1300337C (zh) | 一种细胞因子基因型检测芯片及其用途 | |
CN1548552A (zh) | 精神分裂症易感基因检测方法及易感基因和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ANHUI HUA'ANFO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HUA'ANFO MEDICINE RESEARCH CENTER CO., LTD., BEIJING Effective date: 20121206 Free format text: FORMER OWNER: ANHUI RESEARCH INSTITUTE OF BIOMEDICINE Effective date: 20121206 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100026 CHAOYANG, BEIJING TO: 230032 HEFEI, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121206 Address after: 153, box 81, Medical University Of Anhui, 230032 Mei Shan Road, Anhui, Hefei Patentee after: Huaan Anhui Buddha Pharmaceutical Co., Ltd. Address before: 100026 Beijing city Chaoyang District tianshuiyuan Street No. 6 room 707 Patentee before: Hua'anfo Medicine Research Center Co., Ltd., Beijing Patentee before: Anhui Biological Medical Science Inst. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Reagent kit for predicting serotonin re-uptake inhibitor medicine effect Effective date of registration: 20130523 Granted publication date: 20101103 Pledgee: China Everbright Bank Shenzhen Bagualing branch Pledgor: Huaan Anhui Buddha Pharmaceutical Co., Ltd. Registration number: 2013990000311 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160218 Address after: 518057, Nanshan District hi tech Zone, Shenzhen, a high-tech incubator in No. 16, three, 2, building first, second, building 3, 1, East and 2, 3, and Guangdong Patentee after: Shenzhen Aosa Pharmaceutical Co., Ltd. Address before: 153, box 81, Medical University Of Anhui, 230032 Mei Shan Road, Anhui, Hefei Patentee before: Huaan Anhui Buddha Pharmaceutical Co., Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160705 Granted publication date: 20101103 Pledgee: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgor: Huaan Anhui Buddha Pharmaceutical Co., Ltd. Registration number: 2013990000311 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160705 Registration number: 2013990000311 Pledgee after: China Everbright Bank, Limited by Share Ltd, Shenzhen, Bagualing branch Pledgee before: China Everbright Bank Shenzhen Bagualing branch |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220314 Address after: 518057 the east side of the second floor, the fourth floor and the east side of the fourth floor of the third building of biological incubator, No.16, Gaoxin Zhongyi Road, Yuehai street, Nanshan District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN TAILEDE MEDICAL CO.,LTD. Address before: 518057 the 1st and 2nd floors of Building 2, phase III of biological incubator, No.16, Gaoxin Zhongyi Road, central high tech Zone, Nanshan District, Shenzhen City, Guangdong Province; the east side of the 1st floor and the 2nd and 3rd floors of building 3 Patentee before: SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. |